SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: FNS who wrote (794)10/9/1998 2:55:00 PM
From: Biomaven  Read Replies (2) | Respond to of 965
 
Very nice looking ReoPro study:

biz.yahoo.com

Peter



To: FNS who wrote (794)10/22/1998 12:50:00 AM
From: David S.  Read Replies (2) | Respond to of 965
 
Message 5875922

although earnings estimates for cnto are going south for the winter, merrill contends the stock deserves a 50 P/E. Well hells bells, why not put a 150 P/E on it? Guess since expectations on products currently approved seem to be starting to come down to earth, the company's efforts for RA (the sun god) are more critcal. Egyptian mythology may play a greater role in the future of cnto, more so than investors realize.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News